Real-world experience in the management of CML patients focused on tyrosine kinase inhibitors intolerance and health-related quality of life
{{output}}
Introduction: This study aimed to analyze the survival outcomes and adverse events (AEs) associated with the long-term use of tyrosine kinase inhibitors (TKIs) and to assess health-related quality of life (HRQoL) in patients with... ...
